Nalaganje...
Bevacizumab: Off-label use in ophthalmology
Bevacizumab is a full-length, humanized monoclonal antibody directed against all the biologically active isoforms of vascular endothelial growth factor (VEGF-A). The antibody was initially designed and studied as an anti-angiogenic strategy to treat a variety of solid tumors. After approval by the U...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Medknow Publications
2007
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2635984/ https://ncbi.nlm.nih.gov/pubmed/17951896 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|